LPCN $10-$40Projected revenues for 2026 are 26,000% increase. June 2024 revenue Growth (YoY) 8630.55% After a negative growth 2023. With a wide range of drugs and applications the future seems promising.
LPCN trade ideas
LPCN - Riding the Bullish WaveCurrent Price: $9.45
Date of Analysis: June 14th, 2024
Time Frame: Weekly
Chart Observations:
Moving Averages:
EMA 20 (Close): $5.62 - The stock is trading above the 20-week exponential moving average (EMA), indicating a bullish trend in the short term.
EMA 50 (Close): $4.68 - The stock is also well above the 50-week EMA, reinforcing the strength of the current upward trend over the medium term.
Volume Analysis:
Recent weeks have seen a notable increase in trading volume, particularly with significant green volume bars coinciding with price increases. This suggests strong buying interest and potential continuation of the uptrend.
MACD (Moving Average Convergence Divergence):
MACD Line: 0.6229
Signal Line: 0.4218
The MACD line is above the signal line, a bullish indicator. Moreover, the positive histogram values further support the strength of the current bullish momentum.
ADX (Average Directional Index):
ADX Value: 43.40
With an ADX value of 43.40, this indicates a very strong trend. Values above 25 usually suggest a strong directional movement, enhancing the reliability of the current uptrend.
Price Action:
LPCN has shown a consistent uptrend with higher highs and higher lows over recent weeks. The recent peak has pushed the stock to new highs, suggesting a breakout which could lead to further price discovery upward.
Trading Strategy:
Entry Point:
Consider buying on any minor pullback towards the 20-week EMA ($5.62), using it as a dynamic support level for better risk-reward ratios.
Stop-Loss:
A stop-loss can be strategically placed just below the recent swing low or the 50-week EMA ($4.68) to protect against any unexpected reversals.
Price Target:
The initial price target can be set within the range of $30 to $42.95, given the breakout pattern and strong bullish indicators. Adjust this target as the price action develops and more data becomes available.
Risks:
Volatility:
As with any stock exhibiting strong moves, volatility can increase, leading to potential sharp pullbacks.
Market Sentiment:
Any adverse macroeconomic news or shifts in market sentiment could disproportionately affect stocks at new highs.
Conclusion:
LPCN’s current technical posture is robust, with indicators supporting further upside potential towards the target range of $30 to $42.95. The stock has maintained a strong bullish trend, backed by increasing volume and positive momentum indicators. Traders should monitor key levels closely and adjust their positions based on actual market movements and forthcoming financial data releases.
$LPCN is gonna fall todayPupm&Dump trading strategy idea.
$LPCN is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $1,54;
stop-loss — $1,6;
take-profit — $1,42/MOC
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
LPCN LongWeekly Chart
In Uptrend, sideway, near support
OBV > OBV40 ( in my OBV script, weekly chart uses 40 week)
Entry 1.3
Stop 1
Target 2.3
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
Lipocine looks interestingJust a trading setup I'm monitoring on my watchlist no firm price target as of yet. There is cup with handle pattern that has been forming for months here. After forming the cup and getting rejected at 2.50 USD The stock has been trending down slowly and consolidating in a channel. A break of this channel could prove to be a nice swing trade opportunity.
LPCN long set upNo investment advice!
I do this only for practicing.
I see a cup and handle
Very nice risk / reward here.
Upcoming Catalysts:
LPCN 1144
Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH)
Phase 2
Mid-2021
Phase 2 top-line change in liver fat data met primary endpoint January 12, 2021. 36-week biopsy data are expected mid-2021.
LPCN Entering at Support LevelPrice seems to have a lot of support around 1.80 , which looks like a nice point to enter. I would wait and see what this week holds, as I suspect it could go test that support again. I see this stock as a long-term play, but the price might oscillate around that support once more before rising.
I will pay attention to the MA90 crossover, as it could indicate a downtrend. if it isn't strong enough, I suspect the price to recover quickly and try the 2.25-2.40 resistance zone again.
Trade well!
How much is treatment fo Cirrhosis worth ?First i want to give a shout out to my research department for sliding this across my virtual desk. Jeff you the MAN .
1 in 400 adult in the USA has some form of Cirrhosis 1 in 400 Boomer has that shit . Comes in LPCN with a patented treatment of that deadly condition. Wait they are going to court for that patent Insiders are telling me the case is a slam dunk (trial was to start feb 8 but you know Covid ).. that is probably why Vanguard and Black rock bought over 7% of the float.
Now to the chart. Volume has been increasing ... broke out of ichi cloud after a nice accumulation period. green rectangle is ideal buy zone with obvious Stop loss. Red rectangle is the resistance. imo there is 3 ways to play this ...
1-wait for resistance to be broken and become support 2- be the patient guy with buy orders in the green zone or 3- YOLO market buy and DCA the green zone. Targets be the red lines above it all. how many people have drank too much during this pandemic ? i raise my glass to this one .
LPCN: CUP AND HANDLE PLAY?LPCN :
So what are your thoughts? Does it qualify for a cup and handle ?
Definitely not your typical cup, right? But I do smell coffee here. No cup no coffee.
The pattern is confirmed once we break the previous higher high (the top of the cup).
I'm already in the trade.
Price target on the chart.
Trade safe.
Long | LPCNNASDAQ:LPCN
Possible Scenario: LONG
Evidence: Price Action
This is my idea and could be wrong 100%
* It's a good buy opportunity right now, and it's ready to fly soon.
LPCN Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE
$LPCN - Lipocine Inc. - Common Stock
Initial Alert Price: $1.42
Price High: $2.54
% Gains/Losses: 78.87%
(+59% More Than Expected)
Potential Stop Loss: $2.413
LPCN hit $2.54 in yesterday's pre-market session providing a 78.87% Gain on our initial alert on Dec. 22nd. The stock pulled back to the $2.20 Price Levels and found strong support, so we're expecting it to have continued movement to the upside, retest those $2.50 Levels and potential fall into a continuation pattern. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Wait for it to break resistanceCame across this stock at r/pennystocks. Before buying, wait for it to break the resistance line and the 200 weekly MA.
3rd times a charm?i like these multiple higher lows. very ascending wedge -ish. looks like that local high its having trouble with. failed to break it twice, but still, higher lows. now about to test the 3rd time?! i see it breaking. divergence on the daily macd. first target - local high, but shortly after that is the gap fill...if it keeps up a 3rd target could be next local highs
Look at this GrinderI know bears will say they do not have much money to survive to last 6 month and need to dilute shares. Bulls will uphold Zacks research target to $10.
Am just trying to make sense of technical picture.
So we have a rising 200 ma supporting the rise with 10ema, 20ma and 50ma creating a grinding action.
I am in at a very cheap price. Currently up 133%. Breakout above rectangle would be a good entry. Will exit position if breaks 200ma
Like or comment.
thanks
$LPCN can rise in the next daysContextual immersion trading strategy idea.
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $1,63;
stop-loss — $1,53.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
LPCN FDA Approval
This video discusses some strategies for today.
FDA news was supposed to come in pre-open today but i don't see anything.
Sometimes they are delayed... Happens but No news or anything at the time of this video.
All Information discussed is for EDUCATIONAL Purpose. I am not liable for any gain/loss. Do your own research
and make your own decisions, but this is the SAME advice i would give to my own family.
FDA Approval Pump and Dump- Massive Rally ExpectedFDA Approval on 28th Aug.
- Wait for the DIP to buy in
- Dont wait till FDA approval to AVOID pump and dump
or the FDA results
- Load up
Good price to buy is 1.20 - 1.60 and you need to buy LOADS
and just sell it off once you reach your desired profit.
Lipocine $LPCN 4th Submission Run-up Lipocine Inc $LPCN has a PDUFA on Aug. 28 for Tlando, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men.
Lipocine Announces Derivative Suit Was Dismissed 7/31/2020
www.prnewswire.com
I really like how this chart is setting up over the $1.60 level if volume continues. There is a lot of short squeeze potential in the name, and always manage your risk.
